Epidemiology and health economics
Understanding where the health burden is and whether new vaccines are likely to be cost-effective is essential for the implementation of vaccination programmes. This cross-cutting theme both supports vaccine development and assesses the outcome of vaccine implementation.
- Vaccine-preventable diseases occur all over the world and in many cases may make the greatest impact in developing countries. It is essential that the spread of these infections is understood so that vaccine development can be prioritised appropriately, especially where certain high-risk groups are particularly affected.
- As new vaccines become available, data about disease burden and the predicted benefits of vaccine uptake are necessary to understand whether a vaccine will be effective in the wider population and our ability to provide it to those in need.
Key members of this theme
Dr Victoria Cornelius
Dr Victoria Cornelius
Senior Lecturer in Clinical Trial Statistics
Professor Andrea Crisanti
Professor Andrea Crisanti
Professor of Molecular Parasitology
Professor Christl Donnelly
Professor Christl Donnelly
Professor of Statistical Epidemiology
Dr Ilaria Dorigatti
Dr Ilaria Dorigatti
Lecturer/Sir Henry Dale Fellow
Professor Neil Ferguson
Professor Neil Ferguson
Professor of Mathematical Biology and Head of Department
Dr Tini Garske
Dr Tini Garske
Lecturer in Infectious Disease Analysis
Professor Azra Ghani
Professor Azra Ghani
Chair in Infectious Disease Epidemiology
Professor Nicholas Grassly
Professor Nicholas Grassly
Professor of Infectious Disease & Vaccine Epidemiology
Dr Katharina Hauck
Dr Katharina Hauck
Senior Lecturer in Health Economics
Professor Alison Holmes
Professor Alison Holmes
Professor of Infectious Diseases
Dr Natsuko Imai
Dr Natsuko Imai
Research Associate
Krystal Lau
Krystal Lau
Research Postgraduate
Dr Marisa Miraldo
Dr Marisa Miraldo
Associate Professor in Health Economics
Professor Peter Openshaw
Professor Peter Openshaw
Clinical Consul for the Faculty of Medicine
Professor Steven Riley
Professor Steven Riley
Professor of Infectious Disease Dynamics
Ana Wheelock Zalaquett
Ana Wheelock Zalaquett
Honorary Research Associate